Study: Less is better when it comes to aspirin after heart procedure

12/19/2012 | Modern Medicine

Higher doses of aspirin were associated with greater bleeding risks but not better ischemia outcomes in a study that followed 2,851 people after percutaneous coronary intervention for ST-segment elevation myocardial infarction. The study in the Journal of the American College of Cardiology: Cardiovascular Interventions examined three years of data from the HORIZONS-AMI trial.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD